Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Multiple Myeloma 8Pancreatic Neoplasms 7Neoplasms 6Neoplasms, Plasma Cell 4Myelodysplastic Syndromes 4Colorectal Neoplasms 3Stomatitis 2Skin Neoplasms 2Prostatic Neoplasms 2Ovarian Neoplasms 2Myeloproliferative Disorders 2Leukemia, Myeloid, Acute 2Leukemia 2Inflammation 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Sarcoma 1Recurrence 1Primary Myelofibrosis 1Myofibroma 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Endocrine Neoplasia Type 1 1Mucositis 1Motor Activity 1Lymphoma 1Lung Neoplasms 1Liver Neoplasms 1Limb-girdle muscular dystrophy, type 2C 1

Interventions

Cisplatin 72Brachytherapy 31Radiotherapy 26Paclitaxel 23Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 21human papillomavirus vaccine, L1 type 16, 18 20Topotecan 18Papillomavirus Vaccines 18Carboplatin 18Surveys and Questionnaires 17Bevacizumab 16pembrolizumab 14Radiation 12Gemcitabine 12Early Intervention, Educational 12Colposcopy 12Methods 11Magnetic Resonance Spectroscopy 11atezolizumab 10Radiotherapy, Intensity-Modulated 10Blood Specimen Collection 10Papanicolaou Test 9Docetaxel 9Vaccines, Synthetic 8Platinum 8Nivolumab 8Ipilimumab 8Counseling 81,2-diaminocyclohexaneplatinum II citrate 8Vaccines 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Uterine Cervical Neoplasms × Ascorbic Acid × Clear all
NCT00284427 2016-02-10

Safety of Antioxidants During GYN Cancer Care

University of Kansas Medical Center

Phase 2 Completed
25 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡